Octapharma Chooses Genedata Selector for NGS-Based Cell Line Development

BASEL,Switzerland, Sept. 17, 2020 /PRNewswire-PRWeb/ -- Genedata, the leading provider of enterprise software solutions for biopharmaceutical R&D, today announced that Octapharma, one of the world's leading manufacturers of therapeutic human proteins, has chosen Genedata Selector as its central computational platform to streamline genomics-based cell line development and cell culture optimization workflows.